Cargando…
Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report
BACKGROUND: The BNT162b2 vaccine received emergency use authorization from the U.S. Food and Drug Administration for the prevention of severe coronavirus disease 2019 (COVID-19) infection. We report a case of biopsy and magnetic resonance imaging (MRI)-proven severe myocarditis that developed in a p...
Autores principales: | Agdamag, Arianne Clare C, Gonzalez, Daniel, Carlson, Katie, Konety, Suma, McDonald, William C, Martin, Cindy M, Maharaj, Valmiki, Alexy, Tamas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790078/ https://www.ncbi.nlm.nih.gov/pubmed/35088026 http://dx.doi.org/10.1093/ehjcr/ytac007 |
Ejemplares similares
-
Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report
por: Thomson, Ross J, et al.
Publicado: (2021) -
A case report of multisite arterial thrombosis in a patient with coronavirus disease 2019 (COVID-19)
por: Angelillis, Marco, et al.
Publicado: (2020) -
COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond
por: Fraser, Meg, et al.
Publicado: (2022) -
Case report of heart transplantation for giant cell myocarditis in a patient with common variable immunodeficiency
por: Franzon, Thomas A, et al.
Publicado: (2021) -
Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis
por: Schauer, Jenna, et al.
Publicado: (2022)